Deciphering Risperidone-Induced Lipogenesis by Network Pharmacology and Molecular Validation
Bibliographic Data
| ID | 15518535 |
|---|---|
| Authors | Yun Fu (0000-0002-5098-2853, Tianjin Medical University), Ke Yang (0000-0003-2757-5771, Tianjin Medical University), Yepei Huang (0009-0007-2647-8407, Tianjin Medical University), Yuan Zhang (0000-0002-0902-9585, Tianjin Medical University), Shen Li (0009-0000-7099-087X, Tianjin Medical University, corresponding author), Weidong Li (0000-0003-2754-2726, Tianjin Medical University, corresponding author), Wei-Dong Li |
| Year | 2022 |
| Volume | 13 |
| Pages | 870742-870742 |
| Publication date | 2022-04-18 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Psychiatry (JOURNAL) |
| Journal identifiers | ISSN: 1664-0640 • E-ISSN: 1664-0640 |
| Publisher | Frontiers Media (PUBLISHER • CH) |
| DOI | 10.3389/fpsyt.2022.870742 |
| PMID | 35509887 |
| OpenAlex | W4224136035 |
| Language | EN |
| References cited | 49 |
Risperidone increases adipocyte lipid accumulation by plausibly inhibiting long-chain fatty acid β-oxidation through targeting MAPK14 and MAPK8
Lipid metabolism · Lipogenesis · Psychiatry · Risperidone · Schizophrenia (object-oriented programming · Diabetes, Cardiovascular Risks, and Lipoproteins · Medicine · Neuroscience · Psychology · Schizophrenia research and treatment · Tryptophan and brain disorders · Internal Medicine · Pharmacology
| Highly cited | No |
|---|